- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT00118222
High Light and Low Light Dose PDT in Glioma
A Randomized Prospective Two Arm Clinical Trial of High Light Dose And Low Light Dose PDT in the Treatment of Recurrent Malignant Supratentorial Gliomas Using Porfimer Sodium [Photofrin]
RATIONALE: Photodynamic therapy uses a drug, such as porfimer sodium, that becomes active when it is exposed to a certain kind of light. When the drug is active, tumor cells are killed. Giving photodynamic therapy after surgery may kill any remaining tumor cells.
PURPOSE: This randomized clinical trial is studying two different light doses of photodynamic therapy using porfimer sodium to compare how well they work in treating patients who are undergoing surgery for recurrent malignant astrocytoma.
연구 개요
상세 설명
OBJECTIVES:
- Compare survival of patients undergoing surgical resection for recurrent high-grade malignant supratentorial astrocytoma treated with intraoperative high vs low light dose photodynamic therapy using porfimer sodium.
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to participating center. Patients are randomized to 1 of 2 treatment arms.
All patients receive porfimer sodium IV. One day later, patients undergo craniotomy and tumor resection.
- Arm I: During surgery, patients receive low light dose photodynamic therapy.
- Arm II: During surgery, patients receive high light dose photodynamic therapy. After completion of study treatment, patients are followed at 1 day, 6 weeks, and 3 months and then every 3 months for up to 2 years.
PROJECTED ACCRUAL: Approximately 120 patients will be accrued for this study within 4-5 years.
연구 유형
등록 (실제)
단계
- 3단계
연락처 및 위치
연구 장소
-
-
Ohio
-
Cleveland, Ohio, 미국, 44106-5000
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
DISEASE CHARACTERISTICS:
Histologically confirmed malignant supratentorial astrocytoma, glioblastoma, or mixed oligo-astrocytoma
Grade 3 or 4 tumor, defined as presence of ≥ 2 of the following features:
- Nuclear atypia
- Mitosis
- Endothelial proliferation
- Necrosis
Recurrent disease
- Failed prior surgery and radiotherapy
- Tumor suitable for radical resection by imaging studies
PATIENT CHARACTERISTICS:
Age
- 18 and over
Performance status
- Karnofsky 60-100%
Life expectancy
- At least 3 months
Hematopoietic
- Not specified
Hepatic
- Not specified
Renal
- Not specified
Other
- Not pregnant or nursing
- Fertile patients must use effective contraception
- Willing to avoid direct sun-light exposure for 6 weeks after photodynamic therapy
PRIOR CONCURRENT THERAPY:
Biologic therapy
- Not specified
Chemotherapy
- Not specified
Endocrine therapy
- Not specified
Radiotherapy
- See Disease Characteristics
Surgery
- See Disease Characteristics
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
활성 비교기: Low light dose during surgery
Arm I: During surgery, patients receive low light dose photodynamic therapy.
|
All patients receive porfimer sodium IV.
다른 이름들:
All patients receive porfimer sodium IV.
다른 이름들:
All patients receive porfimer sodium IV.
One day later, patients undergo craniotomy and tumor resection.
|
활성 비교기: High light dose during surgery
Arm II: During surgery, patients receive high light dose photodynamic therapy.
|
All patients receive porfimer sodium IV.
다른 이름들:
All patients receive porfimer sodium IV.
다른 이름들:
All patients receive porfimer sodium IV.
One day later, patients undergo craniotomy and tumor resection.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
기간 |
---|---|
Time to progression and survival measured
기간: at 4-6 weeks post-operatively and then every 3-4 months thereafter
|
at 4-6 weeks post-operatively and then every 3-4 months thereafter
|
공동 작업자 및 조사자
수사관
- 연구 의자: Robert J. Maciunas, MD, Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- CWRU4303
- P30CA043703 (미국 NIH 보조금/계약)
- CASE-4303 (기타 식별자: Case Comprehensive Cancer Center)
- CWRU-00003937
- CWRU-4303 (기타 식별자: Case Comprehensive Cancer Center)
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
porfimer sodium에 대한 임상 시험
-
North Florida/South Georgia Veterans Health SystemAxcan Pharma; North Florida Foundation for Research and Education완전한
-
Paradigm Biopharmaceuticals USA (INC)모집하지 않고 적극적으로
-
Shandong New Time Pharmaceutical Co., LTD아직 모집하지 않음
-
SB Istanbul Education and Research HospitalBezmialem Vakif University모병
-
Cytonet GmbH & Co. KGCRS Clinical Research Services Mannheim GmbH완전한
-
National Taiwan University HospitalTCM Biotech International Corporation모병
-
Shanghai General Hospital, Shanghai Jiao Tong University...아직 모집하지 않음
-
IBSA Farmaceutici Italia Srl모집하지 않고 적극적으로